3-mercaptopropionic acid has been researched along with Melanoma in 2 studies
*Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, XY; Ding, YT; Gao, ZX; Gu, JY; Li, YL; Ren, M; Shen, KJ; Wang, L; Wei, CY | 1 |
| Juzenas, P; Kavaliauskiene, S; Purviniene, R; Rotomskis, R; Steponkiene, S | 1 |
2 other study(ies) available for 3-mercaptopropionic acid and Melanoma
| Article | Year |
|---|---|
Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.
Topics: 3-Mercaptopropionic Acid; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Indoles; Melanoma; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sulfonamides; Vemurafenib | 2022 |
Quantum dots affect expression of CD133 surface antigen in melanoma cells.
Topics: 3-Mercaptopropionic Acid; AC133 Antigen; Antigens, CD; Biomarkers, Tumor; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Flow Cytometry; Glioblastoma; Glycoproteins; Humans; Hyaluronan Receptors; Male; Melanoma; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Phenotype; Prostatic Neoplasms; Quantum Dots; Tellurium | 2011 |